Cullen/Frost Bankers’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $548K | Buy |
6,280
+1,370
| +28% | +$120K | 0.01% | 398 |
|
|
2025
Q1 | $335K | Buy |
4,910
+59
| +1% | +$4.03K | ﹤0.01% | 447 |
|
|
2024
Q4 | $377K | Buy |
4,851
+2,679
| +123% | +$208K | 0.01% | 420 |
|
|
2024
Q3 | $146K | Buy |
2,172
+2,094
| +2,685% | +$140K | ﹤0.01% | 548 |
|
|
2024
Q2 | $8.84K | Buy |
78
+42
| +117% | +$4.76K | ﹤0.01% | 860 |
|
|
2024
Q1 | $4.99K | Buy |
36
+12
| +50% | +$1.66K | ﹤0.01% | 862 |
|
|
2023
Q4 | $2.98K | Buy |
+24
| New | +$2.98K | ﹤0.01% | 914 |
|
|
2023
Q2 | – | Sell |
-12
| Closed | -$1.39K | – | 1165 |
|
|
2023
Q1 | $1.39K | Buy |
+12
| New | +$1.39K | ﹤0.01% | 1120 |
|
|
2022
Q4 | – | Sell |
-20
| Closed | -$2K | – | 1131 |
|
|
2022
Q3 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1046 |
|
|
2020
Q4 | – | Sell |
-8
| Closed | -$1K | – | 1085 |
|
|
2020
Q3 | $1K | Buy |
8
+4
| +100% | +$500 | ﹤0.01% | 1074 |
|
|
2020
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1104 |
|
|
2020
Q1 | – | Sell |
-12
| Closed | -$1K | – | 931 |
|
|
2019
Q4 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 1013 |
|